From BD to Clinical Milestones The Core Trends in Autoimmune Diseases Finally Emerge in 2026 Q1
In Q1 2026, progress in the autoimmune field is no longer characterized by fragmented innovation, but by systematic breakthroughs centered on a handful of core targets. Starting from these targets, the following provides a detailed overview of the most representative BD deals and clinical milestones within each category.